Polyomavirus (Py) large and small tumorantigens together are competent to induce S phase in growth-arrested mouse fibroblasts. The capacity of the large tumorantigen to bind the pocket proteins, pRB, p130 and p107, is important for the transactivation of DNA synthesis enzymes and the cyclins E and A, while the interference of small tumorantigen with protein phosphatase PP2A causes a destabilization of the cdk2 inhibitor p27, and thus leads to strong cyclin E-and cyclin A-dependent cdk2 activity. Py small tumorantigen, in addition, is able to transactivate cyclin A. Hence, this protein might have a much wider effect on gene expression in arrested mouse fibroblasts than hitherto suspected. This may have a profound part in the known capacity of Py to form tumors in mice. Therefore, it was interesting to gain an insight into the spectrum of transcriptional deregulation by Py tumorantigens. Accordingly, we performed microarray analysis of quiescent mouse fibroblasts in the absence and presence of small or large tumorantigen. We found that the viral proteins can induce or repress a great variety of genes beyond those involved in the S phase induction and DNA synthesis. The results of the microarray analysis were confirmed for selected genes by several methods, including real-time PCR. Interestingly, a mutation of the binding site for pocket proteins in case of LT and for PP2A in case of ST has a variable effect on the deregulation of genes by the viral proteins depending on the gene in question. In fact, some genes are transactivated by LT as well as ST completely independent of an interaction with their major cellular targets, pocket proteins and PP2A, respectively.
Introduction
Polyomavirus (Py) can form solid tumors in many different organs of newborn mice and thus must be able to infect and replicate in a great variety of cell types (Benjamin, 2001) . Such cells are in diverse stages of differentiation and are most frequently growth arrested. As the virus requires cells in the S phase for the replication of its own DNA, it must be able to drive the infected cells out of the quiescent state into the S phase. This is accomplished by the activity of three early viral proteins, the large, middle and small tumor antigens (henceforth abbreviated LT, MT and ST, respectively) . LT is a pleiotropic protein that specifically binds to the viral origin of replication and carries helicase activity. In its replication capacity, it combines functions of the ORCs and the MCMs (Bell and Dutta, 2002) of the cellular replication machinery. In addition, it is the major protein involved in creating optimal conditions for virus replication in the host cell by interfering with the cellular mechanisms of growth control (Moran, 1993) . It binds to the underphosphorylated form of the 'pocket proteins', p130, p107 and p110 the retinoblastoma protein (pRB), thereby obstructing the function of these proteins as negative regulators of members of the transcription factor family E2F. This leads to the transcription of a variety of genes whose products play a role in DNA replication (DNA synthesis-and precursor-producing enzymes (Ogris et al., 1993b; Mudrak et al., 1994) and in the initiation and propagation of the S phase (cyclins E and A, Schu¨chner et al., 2001) . MT antigen is the major transforming protein of Py. It interacts with protein phosphatase 2A (PP2A) and several proteins at the inner surface of the cell membrane, thereby initiating signal transduction pathways, including antiapoptotic ones (Gottlieb and Villarreal, 2001) . Therefore, it has been suggested that MT might serve to prevent apoptosis. In case of SV40, this is mediated by the LT antigen that binds and inactivates p53, a capacity lacking in Py LT protein (Pipas, 1992) . In conjunction with LT antigen, ST of polyoma virus and of SV40 are essential for the initiation of the S phase in serum-starved Swiss 3T3 cells (Ogris et al., 1992) and human diploid fibroblasts (Porras et al., 1999) , respectively. ST protein, like MT, interacts with the cellular protein phosphatase PP2A (Campbell et al., 1995) , replacing the B subunit of the trimeric enzyme with consequences for its activity and specificity. This function plays an important role in the activation of the cyclin E and cyclin A-specific protein kinase, cdk2. ST accomplishes this by causing a shift of the cdk inhibitor p27 to its phosphorylated form, which is followed by a rapid destruction of p27 by the ubiquitin-proteasome system (Schu¨chner and Wintersberger, 1999) . Therefore, it is not surprising that ST is also mandatory for the tumorigenic transformation of human diploid cells (Hahn et al., 1999) together with LT protein, mutated Ras and telomerase (Yu et al., 2001; Hahn et al., 2002) . In this context, it is however important to remember that ST antigens from Py and from SV40 were also found to contribute to the transactivation of cyclin A (Porras et al., 1996; Schu¨chner et al., 2001) . ST protein from SV40 had previously been found to be capable of transactivation, but the earlier work concerned viral promoters (Loeken et al., 1988; Bikel and Loeken, 1992; . It was therefore of interest to find out if ST can more widely influence the transcriptional potential of cells.
It is noteworthy that both, LT and ST, evolved to interact with widely used regulators of cell growth, the pocket proteins and PP2A, respectively. These interactions assure that the requirements for virus multiplication can be provided but at the same time makes it likely that a variety of reactions, not necessarily linked to S phase induction, will also be deregulated by the viral proteins with unforeseen consequences for the cell. In order to apprehend the potential of PyT antigens to affect the transcriptional programme of mouse fibroblasts, we carried out a microarray analysis on gene expression in quiescent cells in the absence and in presence of the viral protein. We discovered that T antigens can induce or inhibit the expression of a surprisingly large number of genes. Examples of such genes were studied in more detail and the effect of ST on their expression was compared to that of the LT protein.
Results and discussion

Microarray analysis
We have previously produced cell lines (on the basis of murine Swiss 3T3 cells) that contain the information for Py LT or ST antigen under the control of the dexamethasone-responsive MMTV promoter (Ogris et al., 1992) . These cells do not produce the viral protein if grown in the absence of the hormone. After addition of dexamethasone to a final concentration of 1 mmol/l, viral proteins become detectable after 4 h and reach high levels after about 8 h; levels of T antigen remain high up to 48 h after hormone addition. The level of viral protein reached under these conditions appears to correspond approximately to that produced in infected cells. Lower concentrations of dexamethasone lead to less viral protein, which in case of LT suffices for transactivation but is insufficient to allow the replication of a plasmid carrying a viral origin of replication (Ogris et al., 1993a) . From this result we can exclude that our cells produce levels of viral protein that are far beyond those achieved in virus infection. This cell system enabled us to study gene expression within the same serum-starved, quiescent cells in the absence or in presence of T antigen. We used a mouse cDNA microarray containing about 17 000 cDNAs to search for genes whose expression is altered by PyST and PyLT. Cells were made quiescent by serum starvation for 72 h and the culture was then divided into two equal parts. One was used to isolate RNA from normal quiescent cells kept in the absence of T antigen, the second one received dexamethasone to 1 mmol/l to induce the viral protein and RNA was extracted 28 h later. This time point was chosen because earlier work had shown that it corresponds to the onset of the S phase in cells expressing ST and LT proteins together (Ogris et al., 1992) . T antigen expression was determined prior to and after hormone addition in order to assure the expected absence (before hormone treatment) and presence (after hormone treatment) of viral protein ( Figure 1 ). Swiss 3T3 cells containing no viral information served as a control for effects of dexamethasone that were not due to the activity of T antigen. Total RNA was used for the preparation of cDNA that was thereby labelled with Cy3-dUTP or Cy5-dUTP, respectively. The labelled cDNAs were used for hybridization in the microarray analysis. The experiment was Figure 1 Control of T-antigen expression. Cells were arrested for 72 h and then incubated in the presence ( þ Dex) or in the absence (ÀDex) of dexamethasone (1 mmol/l final concentration). RNA or protein was extracted from these cell cultures 28 h after induction of T antigen. Serum-starved Swiss 3T3 cells (plus or minus dexamethasone) were used as a negative control and b-actin served as a loading control. RT-PCR (upper part) was performed with total RNA from cells expressing ( þ Dex) or not expressing (ÀDex) LT or ST antigen. Western blot analysis (lower part) of protein extracts using an antibody against the N-terminus of Py T antigens. and MCM7, promoter-luciferase constructs were produced and promoter activation was studied after transient co-transfection with T antigen.
Confirmation of microarray data for selected genes
Genes upregulated by viral proteins From the groups depicted in Tables 1 and 2 , we first selected examples of genes whose products are involved in the progression of the G1 phase of the cell cycle and those that have a function during the S phase for further analysis. This selection included genes whose expression was deregulated to different degrees by the viral protein. Using in addition to the wild type, a mutant of ST unable to interact with PP2A, it was observed that this mutation affects the activity of ST on all of the genes examined, albeit to a variable degree, depending on the gene examined. For instance, while the induction of cyclin D1 and that of c-myc is reduced by 80-100% if the interaction site for PP2A was mutated, the transactivation of mcm6 and mcm7 is much less dependent on an interaction with PP2A. In this case, the PP2A-mutant exhibited 40% or more of the activity of the wild-type ST. It is likely that at least that part of the capacities of ST that does depend on an interaction with PP2A influences promoter activity indirectly, by deregulating signal transduction pathways (Sonntag et al., 1993; Frost et al., 1994) or by causing a more direct change in the phosphorylation status of transcriptional regulators. The situation is quite similar in the case of the dependence of LT functions on an intact binding site for pocket proteins except that in this case some of the genes chosen were deregulated completely independent of an interaction of LT with pocket proteins. It should be pointed out that in all experiments we used one and the same cell lines harboring the mutated versions of either ST or LT. The variability of the effect of the mutations therefore cannot be attributed to differences in the cell lines used. Rather, it indicates that ST as well as LT can transactivate or repress certain genes by a mechanism independent of an interaction with PP2A or pocket proteins, respectively. These observations on individual genes agree well with the data obtained on microarray analysis carried out with the PP2A mutant of ST and the pocket protein mutant of LT, respectively (available on request). These data revealed not only a reduced effect on divers genes that are up-or downregulated by the viral proteins, but they in addition disclosed genes that are deregulated only if the major interaction of LT or ST was eliminated by mutation. While nothing is known of potential interactions of ST with cellular partners other than PP2A and chaperones of the dnaK type, interactions in addition to those involving pocket proteins and chaperones are known for LT. For instance, SV40 LT was reported to interact with components of the general transcription machinery (Damania et al., 1998) . Although such an interaction was not so far shown or looked for in Py LT antigen, the functional similarity between SV40 and polyoma LT suggests that it may well exist. If so, it is likely to contribute to the transactivating capacity of this viral protein. Furthermore, LT proteins of both SV40 and polyoma virus were previously shown to bind the coactivator protein CPB/p300 (Eckner et al., 1996; Nemethova and Wintersberger, 1999) , which again may influence gene expression independent of an interaction with pocket proteins. While the cyclins E and A were found earlier to be transactivated by LT and ST, this study includes cyclin D1 as a further target for ST antigen. RT-PCR and real-time PCR (Figure 2 ) support the data obtained in the microarray analysis. This result is in accord with a report on SV40 ST protein, which was also observed to induce cyclin D1 expression in a manner dependent on an interaction with PP2A (Watanabe et al., 1996) . Immunoblotting (not shown) indicates that cyclin D1 protein was high in arrested cells and did not change significantly after T antigen induction or serum addition, suggesting that the protein is rather stable in Swiss 3T3 cells. Py LT antigen transactivated cyclin D1 about six-fold, while the corresponding protein from SV40 was reported to inhibit cyclin D1 expression (Lukas et al., 1994) . C-myc is strongly transactivated by ST (Figure 2 ), while LT had only a minor effect. The strong transactivation of c-myc by ST may be particularly relevant as c-myc modulates the expression of a great variety of genes (Coller et al., 2000; Menssen and Hermeking, 2002; Fernandez et al., 2003) . This raises the possibility that ST changes the expression of some genes through its effect on c-myc. In fact, among the genes observed as regulated by c-myc in all three studies referred to above are those coding for ribosomal proteins, heat shock proteins and nucleolin, which are also found to be upregulated by ST in our analysis.
Many proteins involved in DNA synthesis and precursor production were previously shown to be transactivated by PyLT (Ogris et al., 1993b; Mudrak et al., 1994) . This includes PCNA, which in this study was also found to be induced by ST protein. The list also contains two important proteins of cellular prereplication complexes, MCM6 and MCM7. Both of these proteins were transactivated by LT and ST antigens (Figure 3) . Genes coding for MCM proteins are regulated by E2F (Tsuruga et al., 1997; Ohtani et al., 1999) ; their induction by LT and ST may therefore resemble that of the other E2F-controlled genes reported previously. We have isolated the murine promoters for the mcm6 and the mcm7 gene and created promoter-luciferase constructs for transient transfections together with LT or ST or their mutants (Figure 4) . The results of these assays confirmed those obtained with real-time PCR and RT-PCR. In agreement with the more direct function of LT protein on E2F regulated promoters, transactivation of these promoters in transient transfection assays is consistently stronger by LT than by ST antigen. Considering the coordinated regulation of all six MCM proteins (MCM 2-7) during serum stimulation of REF 52 cells (Ohtani et al., 1999) , it is likely that also the other MCM proteins are transactivated by both T antigens.
Several oncogenes and tumor suppressors exhibit altered expression in the presence of LT or ST. An example is the tumor suppressor protein Rouleau, 1995) . Figure 5 shows the induction of NF2 by LT as well as ST, which is dependent on the interactions with pocket proteins and PP2A, respectively. The NF2 promoter has some similarity to the cyclin A promoter with which it shares binding sites for transcription factors SP1, E2F and NF-Y (Kino et al., 2001 ). This might suggest that its transactivation by the two T antigens may follow similar mechanisms. Surprisingly, however, and in vast contrast to cyclin A, serum addition dramatically reduced NF2 expression, confirming the results of the microarray analysis of serumstimulated cells. The same was observed with the gene coding for the G protein coupled receptor (GPCR) (Figure 6 ). This gene, together with the one coding for myosin, belongs to the large group of genes in the tables listed under genes coding for signal transducers, cell surface proteins and cytoskeletal proteins. Both GPCR and myosin are also targets of the LT protein ( Figure 6 ).
Genes downregulated by viral proteins Among the genes that are strongly repressed by ST are those coding for decorin and cadherin 11 (Figure 7 ). Both of these proteins are located in the cell surface and exhibit various cell-type-specific effects during differentiation and cell growth. For instance, cadherin 11 is upregulated during myoblastic or osteogenic differentiation of C3H10T1/2 and C2C12. In contrast, adipogenic differentiation of these cells as well as of 3T3-L1 cells causes a decrease of cadherin expression . In human osteoblasts, dexamethasone was reported to inhibit cadherin 11 expression . We found that also in Swiss 3T3 cells dexamethasone caused some decrease of cadherin 11 expression, but the effect of ST protein was by far stronger (Figure 7) , excluding that this effect is solely due to the addition of dexamethasone to our cells. Decorin was found to be downregulated in some tumors (for reviews, see for instance Sta¨nder et al., 1999; Kresse and Scho¨nherr, 2001) . It binds to TGF-b and inhibits its activity. On the other hand, it was found to upregulate p21 expression in some tumor cells. Its strong downregulation in our ST expressing cells could thus contribute to the growthinducing potential of the viral protein. Interestingly, downregulation of both of these genes by LT was completely independent of an interaction with pocket proteins. Finally, one group of genes whose expression not unexpectedly is affected by LT and ST involves genes for transcription factors and translational regulators, immune response genes and genes whose products function in degradation pathways. While components of the transcription machinery are frequently upregulated by T antigens (see for instance Felton-Edkins and White, 2002) , many genes of the immune response here were found to be downregulated, thus creating conditions that would allow the virus to escape the cellular immune response.
In summary, this microarray analysis disclosed an astonishingly large number of genes that are up-or downregulated after the expression of PyT antigens in quiescent cells. All selected genes chosen for documentation of their deregulation confirmed the data obtained by the microarray analysis. Considering that the list in Tables 1-4 still misses genes known to code for S phase- specific enzymes and proteins that were already shown or are expected to be transactivated by viral proteins, the total number of genes influenced in their expression by Py T antigens may be even larger. Obviously, the selection pressure on the evolution of Py was to create optimal conditions for virus replication in many different cell types, that is, driving these different cells from the quiescent state into the S phase. This may require interference with different mechanisms of growth regulation and hence with a broad spectrum of transcriptional control processes. One may ask why it needs both LT and ST to drive efficiently Swiss 3T3 cells out of the quiescent state into the S phase (Ogris et al., 1992) , when ST alone is such an efficient deregulator of gene expression. There are several explanations for this: (i) compared with LT, ST is weak in inducing some DNA synthesis-and precursor-producing enzymes such as thymidine kinase (unpublished). (ii) We found earlier that both LT and ST are required to induce sufficiently high levels of cyclin E/cdk2 activity (Schu¨chner and Wintersberger, 1999) . Cyclin E/cdk2 is essential for S phase induction in most vertebrate cells. (iii) By targeting PP2A, an enzyme that is involved in many Figure 4 Effect of LT and ST on the mcm6 and mcm7 promoters. Transient co-transfection assays were performed using mcm6 and mcm7 promoter-luciferase constructs and LT or ST expressing plasmids. For details see Materials and methods. The equal expression of the wild type and mutated viral proteins was verified by immunoblotting using a polyclonal antibody directed towards the LT/ST common region at the N-termini of the viral proteins Figure 5 Induction of the neurofibromatosis gene 2. The antibody used for immunoblotting was NF2 (sc-331) from Santa Cruz cellular regulatory processes, ST may not only affect reactions that favor S phase induction but also some that hinder this process and it may require LT to neutralize these effects.
We do not want to imply that all of the genes deregulated by the viral T antigens are direct targets of these proteins; the expression of some of the genes may be affected by secondary reactions to gene products upor down-regulated by the T antigens. Still, their deregulation in quiescent cells does depend on the activity of the viral proteins. An example is c-myc, which we found to be strongly upregulated by ST but which itself is an important transactivator. Moreover, the products of some of the genes deregulated by LT or ST may have no role in S phase induction but they may nonetheless contribute to tumorigenesis. Tumor formation was often considered to be an accidental reaction following virus infection, initiated by the competence of the viral proteins to interfere with growth control and apoptosis. However, as Py is replicating rather slowly, the formation of tumors may have even been of evolutionary advantage for the virus, if tumor cells create longer-lasting conditions favorable for virus replication.
Materials and methods
Cell culture and stable transfections
Swiss 3T3 fibroblasts and derived cell lines conditionally expressing the Py LT or the Py ST antigen under the control of the dexamethasone-inducible MMTV promoter (Ogris et al., 1992) were grown in Dulbecco's modified Eagles medium containing 10% fetal calf serum, penicillin (60 mg/ml) and streptomycin (100 mg/ml) in a 7.5% CO 2 atmosphere. When the cells reached 80% confluency, they were arrested by serum 
RNA extraction
Total RNA was isolated using TRIzol reagent (Life Technologies/GIBCO-BRL) as recommended by the supplier.
Microarray preparation
The mouse microarrays used contained a set of 17 000 sequence verified mouse cDNA clones printed onto polylysine-coated slides. Prior to use, the arrays were UV-crosslinked, rehydrated in water steam and chemically blocked using 1.37 g of succine anhydride, 90 ml N-methyl-pyrrolidone and 10 ml of 0.2 M boric acid pH 8.0 for 15 min. After blocking, the slides were rinsed in 0.1% SDS and prehybridized with prehybridization buffer containing 210 ml formamide, 120 ml 20 Â SSPE, 60 ml 50 Â Denhardts, 6 ml salmon sperm DNA (10 mg/ml), 190 ml water and 15 ml 20% SDS at 501C for 1 h.
Fluorescent probe preparation
In total, 100 mg RNA in 17 ml water was primed with 2 ml oligodT 12À18 -primer (500 mg/ml) at 651C for 5 min. Reverse transcription was performed in a mixture containing 8 ml 5 Â first-strand reaction buffer provided with SuperScript t II RNase H À Reverse transcriptase (Invitrogen Life Technologies), 4 ml 100 mM dithiothreitol, 4 ml of 10 Â dNTP (5 mM dATP, dCTP, dGTP and 2 mM dTTP), 1 ml RNasin (40 U/ml Promega), 2 ml SuperScript t II RNase H À Reverse transcriptase (200 U/ml Invitrogen Life Technologies), 4 ml of Cy3-dUTP or Cy5-dUTP (1 nM/ml Amersham Pharmacia) and incubated at 421C for 60 min, followed by the addition of another 1 ml SuperScript t II RNase H À Reverse transcriptase for an additional 1 h incubation. The reaction was stopped by incubation at 941C for 3 min. The remaining RNA was eliminated by adding 2 ml RNase ONE t (6 U/ml, Promega), 5 ml 10 Â RNaseONE t reaction buffer and incubating at 371C for 10 min. The Cy3-dUTP and Cy5-dUTP labelled probes were pooled and precipitated with blocking solution containing 3 mg poly(dA) 40À60 , 6 mg tRNA, 15 mg mouse Cot 1 DNA, 33 ml 10 mol/l ammonium acetate and 330 ml 96% ethanol at À801C for 20 min. The pellet was washed with 400 ml 80% ethanol, dissolved in 10.5 ml H 2 O and then mixed with 6 ml 20 Â SSPE, 1.5 ml 50 Â Denhardts solution, 10.5 ml formamide and 0.75 ml 20% SDS. The probe was denatured at 941C for 1 min followed by prehybridization at 501C for 1 h. It was then added to the microarray slides and incubated at 501C overnight.
Data analysis
After the hybridization, the slides were washed in 1 Â SSC, 0.1% SDS, followed by washing with 0.2 Â SSC, 0.1% SDS and finally 0.2 Â SSC. After drying by centrifugation the microarrays were scanned with a Gene Pix 4060 scanner. Analysis was performed using Gene Pix Pro 4.1 microarray information management system (JMIMS) developed by Volker Leidl and Gerald Lo¨ffler (Research Institut of Molecular Pathology, Vienna).
RT-PCR
In total, 10 mg RNA was reverse transcribed to first-strand cDNA using oligo-dT-primer and RevertAid 0 . PCR cycle conditions were the following: initial denaturation was for 2 min at 951C this was followed by 20-25 cycles consisting of 1.5 min at 951C, 1.5 min for annealing (annealing temperatures were adjusted for each primer pair) and 2 min at 721C for synthesis. Dilutions of cDNA were performed to determine the linear range for each primer pair. PCR products were resolved on a 1.5% agarose gel containing ethidium bromide and were visualized with UV light.
Real-time PCR
Quantitative PCR was performed using Light Cycler Fast Start DNA Master SYBR Green I Kit as recommended by the supplier (Roche). The same primers as described in RT-PCR were used to verify the expression of the selected genes. The b-actin gene was chosen for normalization of the data.
Immunoblotting
After 72 h serum starvation and 28 h induction with dexamethasone, cells were harvested and lysed in buffer (20 mM Tris-Cl (pH 8.0), 100 mM NaCl, 1 mM EDTA, 0.5% NP-40) containing complete protease inhibitor cocktail (Boehringer Mannheim) as described elsewhere (Adamczewiski et al., 1993) . Protein concentration was measured with the BioRad protein assay (BioRad) following the manufacturer's instructions. Equal amounts of protein were separated on an 11% SDS-PAGE, transferred onto a nitrocellulose membrane and probed with the indicated antibodies. Antibodies against MCM6 (sc-9843), NF2 (sc-331), cyclin D1 (sc-246) and cadherin-11 (sc-6463) were purchased from Santa Cruz Biotechnology. MCM7 (Ab-1) antibody was purchased from Oncogene. b-Actin (AC-74) antibody was purchased from SIGMA. LT and ST antigens were detected by a rabbit polyclonal antibody directed against the common N-terminal region of these proteins.
Antibody binding was revealed using appropriate peroxidase-conjugated secondary antibodies (Jackson) and ECL reagents (Amersham) following the manufacturer's instruction.
Transient transfection and luciferase reporter assays
Mouse mcm6 and mcm7 promoters were amplified by PCR using the following primers: mcm6: forward 5 0 -CGGGGT ACCGCTTCATGGCGTATGCTT-3 0 ; reverse 5 0 CCGCTCGA GGAGGTCCATGGCGGCGCC-3 0 ; mcm7: forward 5 0 -CGGGGTACCAGGATAC AGTCTTTATAGATGAG-3 0 ; reverse 5 0 -CCGCTCGAGCGCTGCCGGGGACGGTGT-3 0 . The amplified fragments were inserted into the pGL3 Basic Vector (Promega).
Asynchronously growing REF52 cells were seeded at a density of 5 Â 10 4 cells per six-well plate. The next day, the cells were transfected with polyethylenimine (PEI25000) together with plasmid carrying the information for LT or ST (wild type or mutants) under the CMV promoter and a plasmid expressing b-galactosidase as described previously (Schu¨chner et al., 2001) . Subsequently, the cells were arrested by serum deprivation (0.2% serum) for 48 h. Cells were then harvested and luciferase activity was measured in the assay buffer (25 mM Tricine pH 7.8, 0.5 mM EDTA, 0.54 mM Na-Tripolyphosphate, 16.3 mM MgSO 4 Á 7H 2 O, 0.1% Triton X-100, 4.6 mM Luciferin, 1.2 mM ATP and 5.6 mM DTT) using an AutoLuminat. To normalize the transfection efficiency, b-galactosidase activity was measured as described in Sambrook et al. (1989) . The protein concentration was determined and likewise used for normalization. An aliquot of each extract was used for determination of the level of T antigen by immunoblotting.
